Lexie B3 vs Resound Nexia

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.

The Resound Nexia is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,298. In HearAdvisor's lab testing, it earned a SoundScore of 4.0/5 and an A grade, ranking #28 of 39 prescription hearing aids tested. The Nexia demonstrates clear strengths in specific areas. Feedback handling is excellent at 5.0/5, scoring 0.28 points above the category average—users can expect stable performance without whistling during typical daily activities. Own-voice comfort also stands out at 3.6/5, a solid score that sits 0.90 points above average, suggesting wearers may find their own voice sounds more natural compared to many competitors. However, speech performance presents a more mixed picture. Speech in quiet measures 3.2/5—solid in absolute terms but 0.19 points below the category average. More notably, speech in noise scores just 1.0/5, falling 1.11 points below average. This represents a significant limitation for users who frequently encounter challenging listening environments like restaurants or group conversations. Music streaming scores 2.8/5, essentially matching the category average. At this price point, several alternatives deliver stronger overall performance. The Phonak Sphere Infinio, Oticon Intent, and Oticon Real all score notably higher while occupying the same premium tier. Budget-conscious buyers might also consider options like the Jabra Enhance Select 500 at a lower price point with competitive sound quality. The Nexia may be best suited for users who prioritize feedback stability and own-voice comfort over speech-in-noise performance.